Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s241956
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Serum Pleiotrophin as a Diagnostic and Prognostic Marker for Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

P3.16-01 a Multi-Omic Study Reveals BTG2 as a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Tumor Microemboli Diagnostics for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Early-Stage Non-Small Cell Lung Cancer in Asian-Americans in the National Lung Screening Trial

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Small Cell Lung Cancer: Recruitment of Macrophages by Circulating Tumor Cells

OncoImmunology
OncologyAllergyImmunology
2015English

98O: Characterization of Tumor Infiltrating Lymphocytes in Resectable Early Stage Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Cysts Mark the Early Stage of Metastatic Tumor Development in Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

CD24+/CD38- As New Prognostic Marker for Non-Small Cell Lung Cancer

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy